tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Atai Beckley added to Nasdaq Biotechnology Index
PremiumThe FlyAtai Beckley added to Nasdaq Biotechnology Index
11d ago
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
Premium
The Fly
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
14d ago
Atai Beckley management to meet with Cantor
Premium
The Fly
Atai Beckley management to meet with Cantor
18d ago
AtaiBeckley: Strong Buy Rating Backed by Promising Clinical Data and Robust Financial Position
PremiumRatingsAtaiBeckley: Strong Buy Rating Backed by Promising Clinical Data and Robust Financial Position
1M ago
Psychedelic: Atai Beckley, Cybin report quarterly earnings
Premium
The Fly
Psychedelic: Atai Beckley, Cybin report quarterly earnings
2M ago
ATAI Life Sciences’ BPL-003 Gains Momentum with Breakthrough Therapy Designation and Strategic Merger, Reinforcing Buy Rating
Premium
Ratings
ATAI Life Sciences’ BPL-003 Gains Momentum with Breakthrough Therapy Designation and Strategic Merger, Reinforcing Buy Rating
2M ago
ATAI Life Sciences’ BPL-003 Shows Promising Phase 2b Results, Earning Buy Rating
PremiumRatingsATAI Life Sciences’ BPL-003 Shows Promising Phase 2b Results, Earning Buy Rating
2M ago
GH Research price target lowered to $35 from $40 at H.C. Wainwright
Premium
The Fly
GH Research price target lowered to $35 from $40 at H.C. Wainwright
2M ago
Buy Rating Affirmed on Promising Clinical Data and Strategic Developments for AtaiBeckley
Premium
Ratings
Buy Rating Affirmed on Promising Clinical Data and Strategic Developments for AtaiBeckley
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100